This prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of continuous ECG monitoring, followed by annual follow-up for up to 10 years to assess long-term outcomes including stroke, heart failure, and death.
Age ≥60 years
No prior diagnosis of atrial fibrillation
Able to understand the study purpose and willing to provide written informed consent
No severe cardiac disease, acute illness, or contraindication to ECG monitoring
Severe cognitive impairment or inability to cooperate with follow-up assessments
Pregnant or breastfeeding women
Previously diagnosed with atrial fibrillation and already receiving treatment